Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Viking Therapeutics Inc
VKTX
Healthcare
Biotechnology
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for the treatment of metabolic and endocrine disorders. Its clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptors for the potential treatment of various metabolic disorders. It is...
evaluating an oral formulation of VK2735 in a Phase II trial. It is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. Its newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists for the treatment of obesity and other metabolic disorders. In the rare disease space, it is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:VKTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Aug 19, 2025 9:23pm
The discontinuation rate at the high dose is 28 %
but the discontinuation rate for the placebo is 18 % so what is the problem here.
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Aug 19, 2025 9:28am
Sell buddy sell.Wow.
Otherwise you guys out there will be losing your money big time today anyway
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 23, 2025 4:05pm
New Press Release - Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Conference call scheduled for 4:30 p.m. ET todayPhase 3 VANQUISH Registration Trials Underway for VK2735 in ObesityPhase 2 VENTURE-Oral Dosing Trial Enrollment Completed; Top-Line Results Expected 2H25Continued Progress with Amylin Program; IND Planned 4Q25Strong Quarter-End Cash Position of $808...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 16, 2025 4:05pm
New Press Release - Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025
Conference Call Scheduled for Wednesday, July 23 at 4:30 p.m. Eastern Time SAN DIEGO, July 16, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders...
read article.
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Jul 14, 2025 12:29pm
Light the fuse . TIA
$$$$
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Jul 12, 2025 12:21pm
Tip toeing up the wealth ladder.
.
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Jul 08, 2025 12:19pm
Is this it the "Big One" ?
160.00 $$$$$
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Jul 01, 2025 12:14pm
Take it up to 45 before news . TIA
$$$$
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Jul 01, 2025 12:12pm
They must know how the daily trial is coming along .
13 weeks is 91 days , trial begining was announced end of March.
(542)
•••
Galaxym31
X
Post by
Galaxym31
on Jun 26, 2025 10:23am
Feel good.
$$$$$
(542)
•••
Galaxym31
X
Post by
Galaxym31
on May 28, 2025 12:35pm
Bot trading up down up down.
Waiting for the breakout.
(542)
•••
Galaxym31
X
Post by
Galaxym31
on May 23, 2025 11:52am
Selling here shows a lack of risk reward potential IMO.
.
(542)
•••
Galaxym31
X
Post by
Galaxym31
on May 20, 2025 12:06pm
Looking forward I see 120.00
$$$$$
(542)
•••
Galaxym31
X
Post by
Galaxym31
on May 16, 2025 3:30pm
Must be Bots trading this company.
.
(542)
•••
Galaxym31
X
Post by
Galaxym31
on May 15, 2025 2:53pm
Should be getting obvious as to the effects of VK 2735 on
many of the 280 people.
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy